Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
10 p, 856.3 KB Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor / Sureda, Anna (Institut Català d'Oncologia) ; Chabannon, Christian (Institut Paoli-Calmettes) ; Masszi, Tamás (Semmelweis University) ; Pohlreich, David (Charles University Hospital) ; Scheid, Christof (University of Cologne) ; Thieblemont, Catherine (Hôpital Saint-Louis) ; Wahlin, Björn E. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Sakellari, Ioanna (George Papanicolaou General Hospital) ; Russell, Nigel (Nottingham University Hospital) ; Janikova, Andrea (University Hospital Brno (República Txeca)) ; Dabrowska-Iwanicka, Anna (Maria Sklodowska-Curie Institute-Oncology Center) ; Touzeau, Cyrille (CHU Nantes) ; Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Jantunen, Esa (University of Eastern Finland and Kuopio University Hospital) ; van der Werf, Steffie (EBMT Data Office) ; Bosman, Paul (EBMT Data Office) ; Boumendil, Ariane (EBMT Statistical Unit) ; Liu, Qianying (Sanofi Genzyme) ; Celanovic, Marina (Sanofi Genzyme) ; Montoto, Silvia (St Bartholomew's Hospital) ; Dreger, Peter (University of Heidelberg) ; Universitat Autònoma de Barcelona
Plerixafor + granulocyte-colony stimulating factor (G-CSF) is administered to patients with lymphoma who are poor mobilizers of hematopoietic stem cells (HSCs) in Europe. This international, multicenter, non-interventional registry study (NCT01362972) evaluated long-term follow-up of patients with lymphoma who received plerixafor for HSC mobilization versus other mobilization methods. [...]
2020 - 10.1038/s41409-019-0693-z
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 613-622  
2.
12 p, 1.1 MB The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants / Rio-Machin, Ana (Queen Mary University of London) ; Vulliamy, Tom (Queen Mary University of London) ; Hug, Nele (University of Edinburgh) ; Walne, Amanda (Queen Mary University of London) ; Tawana, Kiran (Addenbrookes Hospital (Cambridge, Regne Unit)) ; Cardoso, Shirleny (Queen Mary University of London) ; Ellison, Alicia (Queen Mary University of London) ; Pontikos, Nikolas (Queen Mary University of London) ; Wang, Jun (Queen Mary University of London) ; Tummala, Hemanth (Queen Mary University of London) ; Al Seraihi, Ahad Fahad H. (Queen Mary University of London) ; Alnajar, Jenna (Queen Mary University of London) ; Bewicke-Copley, Findlay (Queen Mary University of London) ; Armes, Hannah (Queen Mary University of London) ; Barnett, Michael (University of British Columbia) ; Bloor, Adrian (Christie Hospital) ; Bödör, Csaba (Semmelweis University) ; Bowen, David (St James's University Hospital) ; Fenaux, Pierre (Université Paris) ; Green, Andrew (Our Lady's Children's Hospital) ; Hallahan, Andrew (Queensland Children's Hospital (Austràlia)) ; Hjorth-Hansen, Henrik (St Norwegian University of Science and Technology) ; Hossain, Upal (Barts NHS Trust) ; Killick, Sally (Royal Bournemouth General Hospital (Dorset, Regne Unit)) ; Lawson, Sarah (Birmingham Children's Hospital) ; Layton, Mark (Hammersmith Hospital (Londres)) ; Male, Alison M. (Great Ormond Street Hospital for Children (Londres)) ; Marsh, Judith (King's College Hospital NHS Foundation Trust) ; Mehta, Priyanka (University Hospitals Bristol NHS Foundation Trust) ; Mous, Rogier (Universitair Medisch Centrum Utrecht) ; Nomdedeu, Josep (Institut d'Investigació Biomèdica Sant Pau) ; Owen, Carolyn (Foothills Medical Centre) ; Pavlu, Jiri (Hammersmith Hospital (Londres)) ; Payne, Elspeth M. (University College London) ; Protheroe, Rachel E. (University Hospitals Bristol NHS Foundation Trust) ; Preudhomme, Claude (Universitaire de Lille. Jean-Pierre Aubert Research Center) ; Pujol-Moix, Nuria (Institut d'Investigació Biomèdica Sant Pau) ; Renneville, Aline (Broad Institute of MIT and Harvard) ; Russell, Nigel (Nottingham University Hospitals NHS Trust (Regne Unit)) ; Saggar, Anand (St George's Hospital Medical School) ; Sciuccati, Gabriela (Hospital de Pediatría "Prof. Dr. Juan P. Garrahan") ; Taussig, David (Royal Marsden Hospital (Regne Unit)) ; Toze, Cynthia L. (University of British Columbia) ; Uyttebroeck, Anne (University Hospitals Leuven (Bèlgica)) ; Vandenberghe, Peter (University Hospitals Leuven (Bèlgica)) ; Schlegelberger, Brigitte (Medizinische Hochschule Hannover) ; Ripperger, Tim (Medizinische Hochschule Hannover) ; Steinemann, Doris (Medizinische Hochschule Hannover) ; Wu, John (British Columbia Children's Hospital (Vancouver, Canadà)) ; Mason, Joanne (Birmingham Women's NHS Foundation Trust) ; Page, Paula (Birmingham Women's NHS Foundation Trust) ; Akiki, Susanna (Qatar Rehabilitation Institute) ; Reay, Kim (Birmingham Women's NHS Foundation Trust) ; Cavenagh, Jamie D. (Barts NHS Trust) ; Plagnol, Vincent (University College London) ; Caceres, Javier F. (University of Edinburgh) ; Fitzgibbon, Jude (Queen Mary University of London) ; Dokal, Inderjeet (Barts Health NHS Trust) ; Universitat Autònoma de Barcelona
The inclusion of familial myeloid malignancies as a separate disease entity in the revised WHO classification has renewed efforts to improve the recognition and management of this group of at risk individuals. [...]
2020 - 10.1038/s41467-020-14829-5
Nature communications, Vol. 11 (february 2020)  

Vegeu també: autors amb noms similars
3 Russell, N.
8 Russell, Norman H.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.